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Introduction: Studying of various aspects of interaction doctor–parents–patient
is one of the most actual problems in paediatrics. To assess patient compliance
a variety of methods are used. The most effective, non-invasive and fastest for
practical medicine is the questionnaire method.
The aim of our work was to ﬁnd correlations between different aspects of compli-
ance to treatment concerning parents of children with CF and to evaluate overall
compliance both at general and individual levels.
Methods: 58 parents whose children suffer from CF were surveyed. The survey was
conducted by interviewing, with using of developed questionnaire which includes
31 questions. Statistical analysis carried out in the environment for statistical
computing R 3.0.1.
Results: We assume the values of the compliance score <70% as a low level of
compliance, the values from 70% to 90% − medium level and above 90% − high
level. 24% of respondents were having low level of compliance, 50% medium, and
26% high.
Conclusions: The questionnaire and the results of his application will help to
practitioners to ﬁnd answers on various questions about the collaboration with
patients and to understand the behavior of families with CF child.
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Objectives: Adherence to medications in cystic ﬁbrosis (CF) is poor. Studies
demonstrated adherence rates of 40−50%. Poor adherence has been associated
with lower lung function studies (PFTs) and greater frequency of pulmonary
exacerbations.
Methods: A retrospective review of prescription reﬁll data over 5 years was
conducted for several CF medications. Adherence was deﬁned as having reﬁlled
at least 75% of the prescribed medications. PFTs, body mass indices (BMI) and
hospitalization rates over the study period were collected.
Results: Reﬁll data were obtained for 177 patients, divided into 3 groups:
(1) 0−5 years, (2) 6−12 years, (3) 13−21 years. Groups 1 and 2 had higher PFTs
at baseline (p = 0.0003) and over the course of the study (p< 0.0001). Group 1
had an increase in PFTs over time, Group 2 had a decline (p = 0.003). Adherence
was highest in Group 1 (p = 0.011). Adherence to hypertonic saline (IHS) was
signiﬁcantly higher in Groups 1 and 2 compared to Group 3 (p = 0.028). Adhering to
IHS resulted in a signiﬁcant improvement in PFTs in Group 2 (p = 0.025). Adhering
to pancreatic enzymes (PE) resulted in a signiﬁcant improvement in BMI percentile
after controlling for age, gender and time (p = 0.029). There was a trend towards
improved adherence to Pulmozyme in Group 1 compared to other groups. There
was a decrease in adherence to vitamins over time in all age groups (p = 0.007).
Adherence to TOBI showed lower PFTs (p = 0.002) and BMI percentiles (p = 0.019).
Conclusion: Age was a strong predictor of adherence, with group 1 having better
adherence. IHS and PE resulted in improved BMI. IHS improved PFT. TOBI use
was associated with lower PFTs and BMI, likely due to patients being sicker.
272 The impact of disease severity and clinical variation on
self-reported adherence
N. Shaw1, H. White2, S. Denman1, D. Peckham1. 1Adult Cystic Fibrosis Unit,
Leeds, United Kingdom; 2Leeds Metropolitan University, Leeds, United Kingdom
Objectives:We have previously shown that coefﬁcient of variation (CoV) FEV1 is a
predictor of self-reported adherence, but that disease severity is not. The aim of this
study was to determine whether the level of self-reported adherence alters according
to disease severity and investigate the relationship between clinical variation and
disease severity.
Methods: Patients were classiﬁed as Band1/1A [6%]; 2 [21.6%]; 2A [41.8%];
3 [19.6%]; 4 [9.1%]; 5 [2.8%] according to national standard criteria and self-
reported adherence noted from a previous study (CFQ-R self-report). Coefﬁcients
of variation for FEV1, weight and CRP, were calculated from all contact points over
the previous year and days iv therapy were noted. All measures were compared
across disease severity bandings (ANOVA one-way).
Results: Differences across Bands were demonstrated for all parameters. Self-report
adherence did not show a consistent trend, although iv antibiotic treatment, CoV
weight and FEV1 increase with severity. Band 4 had the lowest self-report adherence
and highest variation in CRP.
Table 1.
Measure Band 1/1A Band 2 Band 2A Band 3 Band 4 Band 5 ANOVA
Self-reported adherence (%) 93.5±5.1 74.7±13.5 81±15.5 67.4±17.4 58.5±27.7 66.8±20.8 F(5,242) = 2.33,
p = 0.004
Coefﬁcient of variation
FEV1 (%) 6.7±3.5 13.2±7.5 9.0±5.3 13.1±5.6 17.5±4.6 18.2±11.7 F(2,27) = 7.58,
p< 0.001
weight (%) 2.3±1.9 2.8±1.6 2.3±1.4 3.2±1.2 5.4±6.8 5.6±6.9 F(5,243) = 3.35,
p = 0.006
CRP (%) 37.5±43.7 31.8±43.6 41.0±45.7 47.8±46.8 69.6±46.6 47.5±38.5 F(5,243) = 4.51,
p< 0.001
IV therapy (days) 24.5±28.9 10.9±20.4 21.1±25.5 36.0±30.4 79.5±37.3 98.0±126.3 F(5,243) = 20.8,
p< 0.001
Conclusion: Coefﬁcient of variation for clinical markers of disease show signif-
icant increasing trends with advancing disease severity. In contrast self-reported
adherence decreases from Band 1 to Band 4 and improves in late stage disease
suggesting earlier intervention to prevent poor adherence is required.
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Objectives: An electronic clinical record was implemented coding for all variables
of CF, captured at each contact. Longitudinal patterns of clinical variation have
emerged that suggest a relationship between variation in lung function and adher-
ence. Our aim was to determine the accuracy of self-reported adherence and explore
its relationship with clinical variation.
Methods: Patients completed a self-report of adherence (CFQ-R) and consented to
pharmacy script data collection (previous 6 months). Coefﬁcients of variation (CoV)
for FEV1, weight and CRP were calculated from all clinical contacts within the
previous year. Age, gender, microbiology, disease severity, medication, lung function
and anthropometric measures were collected.
Results: 250 patients [age 29.7±9.2 yrs, 58.6% M, baseline BMI 22.5±3.8 kg/m2,
FEV1 61.3±25.1%, FVC 79.4±23.1%] completed the study. Pharmacy script data
was available for 106 patients. Self-reported adherence and CoV FEV1 were
inversely related, but were absent for CoV CRP and CoV weight.
Adherence measure Correlations with self-report adherence Descriptive statistics
Measure Self-reported
adherence
(%)
Pharmacy
collection
(%)
p FEV1
coefﬁcient
variation (%)
p Pharmacy
discrepancy
(%)
p
Total adherence 77.7±17.5 0.61 <0.001 −0.16 <0.001 14.3 <0.001
Aerosol to thin mucus 73.0±37.8 0.51 <0.001 −0.11 0.06 19.5 <0.001
Aerosol to open airway 82.3±31.9 0.34 <0.001 0.001 0.47 4.5 0.24
PERT 91.4±21.3 0.45 <0.001 −0.21 <0.001 23.6 <0.001
Vitamins 88.2±27.2 0.46 <0.001 −0.03 0.35 24.7 <0.001
Oral nutritional supplements 64.1±39.8 0.51 <0.001 −0.20 0.01 18.1 <0.001
Oral antibiotics 86.4±26.6 0.32 <0.001 −0.15 0.01 19.5 <0.001
Nebulised antibiotics 67.4±9.1 0.55 <0.001 −0.19 0.01 .1 0.43
Conclusion: Self-report adherence consistently exceeds medication collection.
Coefﬁcient variation of FEV1 may be an indirect measure of adherence.
